Atlas FDA

Solesta Injectable Gel

FDA premarket approval P100014/S025 · decided 2020-02-27

Approval details

PMA number
P100014
Supplement
S025
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Solesta Injectable Gel
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Palette Life Sciences
Date received
2020-01-29
Decision date
2020-02-27
Days to decision
29 days
Decision code
OK30
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Santa Barbara, CA
Statement
Use a resistometer in the D-value determination for Biological Indicators.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Barrigel Injectable Gel (K220641)Palette Life Sciences2022-05-26